Markers of infection in inpatients and outpatients with acute Q-fever

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 11, 2009, Pages 1407-1409

  De Wit, Norbert C J ^a   De Jager, Cornelis P C ^a   Meekelenkamp, Jamie C E ^a   Schoorl, Marianne ^b   Van Gageldonk Lafeber, Arianne B ^c   Leenders, Alexander C A P ^a   Kusters, Ron ^a   Wever, Peter C ^a  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

^b Location Alkmaar   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Acute query fever (Q fever); C reactive protein; Infection markers; Leukocyte count; Procalcitonin

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN; UREA;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BLOOD PRESSURE; BREATHING RATE; CONFUSION; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; HOSPITAL PATIENT; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; OUTPATIENT; PNEUMONIA; PRIORITY JOURNAL; Q FEVER; RESPIRATORY TRACT INFECTION; SCORING SYSTEM; THORAX RADIOGRAPHY;

ACUTE DISEASE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; HUMANS; INPATIENTS; LEUKOCYTE COUNT; OUTPATIENTS; PNEUMONIA; PROTEIN PRECURSORS; Q FEVER; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

BACTERIA (MICROORGANISMS); COXIELLA BURNETII; NEGIBACTERIA;

EID: 73349132035     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.307     Document Type: Article

References (12)

1. Derrick E. The Query Fever - the Elkington Oration. Queensland Health 1964;1:1-20.
2. Tissot Dupont H, Raoult D, Brouqui P, Janbon F, Peyramond D, Weiller PJ, et al. Epidemiologic features and clinical presentation of acute Q fever in hospitalized patients: 323 French cases. Am J Med 1992;93:427-434
3. Schimmer B, Morroy G, Dijkstra F, Schneeberger PM, Weers-Pothoff G, Timen A, et al. Large ongoing Q-fever outbreak in the south of The Netherlands. Euro Surveill 2008;13:pii 18939.
4. Steinbach G, Rau B, Debard AL, Javourez JF, Bienvenu J, Ponzio A, et al. Multicenter evaluation of a new immunoassay for procalcitonin measurement on the Kryptor System. Clin Chem Lab Med 2004;42:440-449
5. Algeciras-Schimnich A, Preissner CM, Theobald JP, Finseth MS, Grebe SKG. Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma. J Clin Endocrinol Metab 2009;94:861-868
6. Lim WS, Van Der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58: 377-382
7. Müller B, Prat C. Markers of acute inflammation in assessing and managing lower respiratory tract infections: focus on procalcitonin. Clin Microbiol Infect 2006; 12(Suppl 9):8-16.
8. Fields BS, Benson RF, Besser RE. Legionella and Legionnaires' disease: 25 years of investigation. Clin Microbiol Rev 2002;15:506-526
9. De Jager CP, De Wit NC, Weers-Pothoff G, Van Der Poll T, Wever PC. Procalcitonin kinetics in Legionella pneumophila pneumonia. Clin Microbiol Infect. In press.
10. Krüger S, Ewig S, Marre R, Papassotiriou J, Richter K, von Baum H, et al. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J 2008;31:349-355
11. Volanakis JE. Human C-reactive protein: expression, structure, and function. Mol Immunol 2001;38:189-197
12. Zusman T, Yerushalmi G, Segal G. Functional similarities between the icm/dot pathogenesis systems of Coxiella burnetii and Legionella pneumophila. Infect Immun 2003;71:3714-3723